Work

The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation

Year: 2013

Type: article

Source: Cell stem cell

DOI: 10.1016/j.stem.2013.06.003

Authors: Su Jung Song, Keisuke Ito, Ugo Ala, Lev Kats, Kaitlyn Webster, Su Ming Sun, Mojca Jongen-Lavrencic, Katia Manova-Todorova, Julie Teruya-Feldstein, David E. Avigan, Ruud Delwel, Pier Paolo Pandolfi

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Erasmus MC, Memorial Sloan Kettering Cancer Center

Language: English

Topic: MicroRNA in disease regulation

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: The Co-Clinical Trial Project, G4188066891, Epigenetic regulation by microRNA of MDS pathogenesis, PTEN in ontogenesis and tumor suppression, Targeting PML for therapy in leukemia-initiating cells, G8800716661, Cancer Center Support Grant, The Roles of Lipid Metabolism in the Maintenance of Hematopoietic Stem Cells

OpenAlex ID: W2053930062

FWCI: 16.51

Cites: 47

Cited by: 326

Related to: 10